| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/18/2011 | CN102058872A Medicinal composition containing Lysinopril and amlodipine besilate and preparation method thereof |
| 05/18/2011 | CN102058871A Chinese medicine effective part composition with antitumor effect and preparation method thereof |
| 05/18/2011 | CN102058620A Fistula affused liquid medicine for anal fistula |
| 05/18/2011 | CN102058597A Use of flibanserin in the treatment of sexual disorders |
| 05/18/2011 | CN102058565A Novel insulin inhalation aerosol powder and preparation method thereof |
| 05/18/2011 | CN102058546A Freeze-drying preparation for recombinant swine alpha-interferon and preparation method and usage thereof |
| 05/18/2011 | CN102058539A Process for preparing composite fine insulin particles by applying supercritical fluid crystallization technology |
| 05/18/2011 | CN101481422B Antineoplastic target fusion protein with release switch and use thereof |
| 05/18/2011 | CN101328207B Citrus fruit fly antibacterial peptide, preparation and use thereof |
| 05/18/2011 | CN101288686B Health preparation for increasing bone density and preparation method thereof |
| 05/18/2011 | CN101102785B Prevention of vertical endoparasite infections |
| 05/18/2011 | CN101072875B Novel cancer antigen peptide and the use thereof |
| 05/18/2011 | CN101048081B Nutritional and/or pharmaceutical preparation for use in prophylaxis and treatment of disturbances in microelements absorption from the alimentary canal |
| 05/18/2011 | CN101012455B Deactivation method of biochemistry substance, preparing method of cardiomyopeptidin and use of cardiomyopeptidin |
| 05/17/2011 | USRE42375 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 05/17/2011 | US7943757 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA) |
| 05/17/2011 | US7943738 IL-17 receptor like molecules and uses thereof |
| 05/17/2011 | US7943730 Genes and polypeptides relating to human pancreatic cancers |
| 05/17/2011 | US7943729 Dominant B cell epitopes and methods of making and using thereof |
| 05/17/2011 | US7943728 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation |
| 05/17/2011 | US7943581 Cell penetrating peptides for intracellular delivery of molecules |
| 05/17/2011 | US7943580 Polypeptide and the use thereof |
| 05/17/2011 | US7943579 Osteogenic implant matrices and endosseous tooth implants with improved osteointegration properties |
| 05/17/2011 | US7943578 tripeptide Leu-Val-Tyr as hypotensive agent for reducing blood pressure; edible; being of food origin; from sesame meal |
| 05/17/2011 | US7943577 Alpha-fetoprotein peptides and uses thereof |
| 05/17/2011 | US7943576 Methods of using enterostatin as inhibitor of angiogenesis |
| 05/17/2011 | US7943575 Sustained release drug formulations containing a carrier peptide |
| 05/17/2011 | US7943574 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 05/17/2011 | US7943573 Methods for treatment of distraction osteogenesis using PDGF |
| 05/17/2011 | US7943572 Superior control of blood glucose in diabetes treatment |
| 05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
| 05/17/2011 | US7943569 Extracellular protease-activated prodrug comprising a hydrophilic matrix having a therapeutic agent linked thereto via an extracellular protease substrate peptide; e.g. cisplatin conjugated to carboxy groups of an oligopeptide matrix metalloprotease substrate's aspartic acid unit; tissue-targeted therapy |
| 05/17/2011 | US7943568 Antitumor agents |
| 05/17/2011 | US7943375 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 05/17/2011 | US7943340 Fungal dipeptidyl peptidase IV (DPPIV) enzyme for reagent use |
| 05/17/2011 | US7943338 Autoimmune conditions and NADPH oxidase defects |
| 05/17/2011 | US7943312 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides |
| 05/17/2011 | US7943302 C20ORF23 as modifier of the IGFR pathway and methods of use |
| 05/17/2011 | US7943292 Physiologically acceptable aqueous solutions and methods for their use |
| 05/17/2011 | US7943178 Methods and compositions for delivering peptides |
| 05/17/2011 | US7943156 Use of peptides of general formula I X-SEQ ID No.1-Y in the preparation of cosmetic compositions which are intended to improve the firmness of the skin by increasing cell adhesion |
| 05/17/2011 | US7943153 Vaccines for Mycoplasma bovis and methods of use |
| 05/17/2011 | US7943152 By injection into the eyelid or conjunctiva to reduce secretions from the meibomian glands; nonsurgical; antisecretory agents |
| 05/17/2011 | US7943149 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 05/17/2011 | US7943146 Immunizing compositions comprising HIV-1 proviral constructs with an inactive p6 gag TSG101 UEV binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface |
| 05/17/2011 | US7943138 Survivin peptides as cancer vaccines |
| 05/17/2011 | US7943137 FPRL1 ligands and use thereof |
| 05/17/2011 | US7943132 Methods of treating pain using antagonists of IL-31, IL-31RA and/or OSMRB |
| 05/17/2011 | US7943131 Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists |
| 05/17/2011 | US7943128 Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase |
| 05/17/2011 | US7943127 Defense and counter-defense compositions and methods |
| 05/17/2011 | US7943126 Compositions and methods for treating hypophosphatasia |
| 05/17/2011 | US7943124 Composition for immunostimulation |
| 05/17/2011 | US7942846 Needleless syringe using supersonic gas flow for particle delivery |
| 05/17/2011 | CA2576069C Detoxifizyme with activity of transforming aflatoxin and the gene encodes thereof |
| 05/17/2011 | CA2466525C Synthesis of small particles |
| 05/17/2011 | CA2451521C Use of poly-glu, tyr for neuroprotective therapy |
| 05/17/2011 | CA2425489C Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis |
| 05/17/2011 | CA2423358C Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 05/17/2011 | CA2422580C Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities |
| 05/17/2011 | CA2397194C Alpha v integrin receptor antagonists |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/17/2011 | CA2353553C Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia |
| 05/17/2011 | CA2320100C High affinity nucleic acid ligands of complement system proteins |
| 05/17/2011 | CA2308007C Enhancer for antibody to lymphocytic tumors |
| 05/17/2011 | CA2197672C Tetrahydrofuran antifungals |
| 05/13/2011 | CA2685638A1 Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin |
| 05/13/2011 | CA2685636A1 Method of treatment of diabetes type 2 comprising add-on therapy to metformin |
| 05/12/2011 | WO2011057251A2 Treatment of heart disease |
| 05/12/2011 | WO2011057249A2 Treatment of heart disease |
| 05/12/2011 | WO2011057243A2 Administration of plant expressed oral tolerance agents |
| 05/12/2011 | WO2011057224A2 Zwitterionic polymer bioconjugates and related methods |
| 05/12/2011 | WO2011057160A2 Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120 |
| 05/12/2011 | WO2011057081A1 Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
| 05/12/2011 | WO2011057027A2 Method for treating heart failure with stresscopin-like peptides |
| 05/12/2011 | WO2011057021A1 Quantitation of insulin-like growth factor-i and insulin-like growth factor-ii with high-resolution mass spectrometry |
| 05/12/2011 | WO2011056972A2 Compositions and methods of treating a t cell mediated disorder |
| 05/12/2011 | WO2011056961A2 Method and compositions for suppression of aging |
| 05/12/2011 | WO2011056930A2 Fragile x mental retardation protein (fmrp), compositions, and methods related thereto |
| 05/12/2011 | WO2011056896A1 Methods for treating fatty liver disease |
| 05/12/2011 | WO2011056850A2 Treatment of chronic constipation |
| 05/12/2011 | WO2011056793A2 Composition, method, and kit for alpha-1 proteinase inhibitor |
| 05/12/2011 | WO2011056721A2 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines |
| 05/12/2011 | WO2011056713A2 Glp-1 receptor agonist compounds for obstructive sleep apnea |
| 05/12/2011 | WO2011056502A1 Bone morphogenetic protein receptor type ii compositions and methods of use |
| 05/12/2011 | WO2011056494A1 Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations |
| 05/12/2011 | WO2011056477A2 Methods for treating inflammation and oxidative stress related diseases |
| 05/12/2011 | WO2011056447A2 Methods and kits for preventing hypoglycemia |
| 05/12/2011 | WO2011056416A2 Cardiomyocyte production |
| 05/12/2011 | WO2011056382A1 Angiogenesis promoted by caged growth factors |
| 05/12/2011 | WO2011056116A1 Composition for promoting wound healing |
| 05/12/2011 | WO2011056073A2 Novel compounds for modulating neovascularisation and methods of treatment using these compounds |
| 05/12/2011 | WO2011056033A2 Pharmaceutical composition for preventing / treating trpv1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient |
| 05/12/2011 | WO2011055980A2 Composite of a protein comprising zinc oxide-bonding peptides and zinc oxide nanoparticles, and use thereof |
| 05/12/2011 | WO2011055888A1 Nanoparticle-based gene delivery systems |
| 05/12/2011 | WO2011055880A1 Novel peptide promoting the expression of bdnf, and pharmaceutical composition including same for preventing and treating alzheimer's and parkinson's diseases |
| 05/12/2011 | WO2011055311A1 Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses |
| 05/12/2011 | WO2011055089A1 Production of recombinant factor ix in a human hepatocyte cell line |
| 05/12/2011 | WO2011055047A1 Aqueous composition comprising gold nanoparticles, serum albumin and/or collagen for laser tissue welding |
| 05/12/2011 | WO2011054993A1 Peptides for the treatment of ocular hypertension and/or glaucoma |